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Yvs 7.4%, p¼0.42), mortality (13.7% vs 13.2%, p¼0.28), and cardiac death (6.3% vs
8.0%, p¼0.15) between the two groups. Subgroup analysis in randomized patients
showed no signiﬁcant differences in MACE (9.4% vs 18.4%, p¼0.39), TLR (3.3% vs
12.0%, p¼0.17), mortality (6.3% vs 14.3%, p¼0.20), and cardiac death (6.3% vs 7.3%,
p¼0.90).
CONCLUSIONS One-year clinical outcomes following EES and PES implantations are
similar in dialysis patients.
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BACKGROUND Swine model plays an instrumental role in the assessment of vascular
healing response to implantable device. Restoration of vasomotion has been reported
as a key feature of following DES with biodegradable polymer and fully bioabsorbable
scaffold. So far, evaluation of invasive vasomotion response to acetylcholine (Ach) in
naïve health miniswine coronary is lacking. Therefore, we aimed to study the vaso-
motion response in cath lab setting.
METHODS Seventy coronary arteries (LAD¼24, LCX¼23 and RCA¼23) from 30 healthy
adult animals underwent vasomotor function evaluation. Endothelium-dependent
function was assessed by infusion of incremental Ach at doses of 10-6 and 10-5 mol/L.
Followed by baseline angiography, Ach was administrated via a coronary infusion
catheter (Ultra-Fuse, Boston Scientiﬁc) in proximal of artery with 1 ml/min for 2min.
Coronary angiography was performed 30s after each dose with 5min intervals.
Endothelium-independent function was evaluated by NTG (200mg). The mean
luminal diameter of mid-artery in a length of 20mmwas measured by QCA. Responses
to infusions of Ach and NTG were expressed as percentages of diameter changes from
baseline.
RESULTS Animals were tolerated well without hemodynamic and other complica-
tions during test. There were no differences of lumen diameter among groups from
baseline angiograph (LAD, 2.750.29mm; LCX, 2.670.31mm; and RCA,
2.670.21mm; p>0.05 respectively). However, dilation of right coronary artery
(RCA,3.34.3%) was signiﬁcant more than both LAD (0.54.6%, p¼0.02) and LCX
(-1.24.2%, P¼0.002) in response to low-dose of Ach. All of the three epicardial ar-
teries had a mild vessel constriction instead of dilation to response the high-dose of
Ach. No difference was detected regard the percentage of diameter changes
(LAD, -3.97.9%; LCX, -4.57.9%; and RCA, -5.713.8%; p>0.05 correspondingly).
NTG-induced endothelium-independent vasorelaxation was comparable between
LAD and RCA (6.755.9% and 6.65.4%; p>0.05). LCX (3.35.2%) relaxation was
signiﬁcantly less in response to NTG when compared to LAD and RCA (p¼0.04,
individually).
CONCLUSIONS Healthy adult miniswine is FDA accepted model to evaluate novel
coronary device in preclinical study because their size and anatomy are comparable to
human. The data demonstrated that dilation of epicardial vessels in response to
endothelium-dependent Ach challenge is only occurred at lower dose. The preclinical
implications of these ﬁndings are potentially useful for design pf preclinical vaso-
motion study.
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BACKGROUND While drug-eluting stents (DES) have recently improved their efﬁcacy
and safety proﬁles, differences in stent deliverability among various coronary stents
have not been systematically evaluated. The aim of this bench test study was to
evaluate the impact of stent length on stent deliverability between ﬁrst and second
generation DES systems.
METHODS Three coronary stent systems (Bx Velocity, Integrity and Multi-link 8),
using 6 of each, were assessed with 3 bench test models: 135 degree (simple model),
90 degree (complex model) and coronary model (coronary). Stent delivery systems
were inserted into each model using a dedicated machine and the delivery force was
computed, measured, and compared.
RESULTS For ﬁrst generation DES, long stent systems showed deliverability with
signiﬁcantly greater force compared with short stent systems regardless of bench test
model. For second generation DES, complex and coronary model showed similar force
for both short and long stent, however, simple model revealed greater force in long
stent systems compared with short stent systems.
CONCLUSION Our results suggest that second generation DES platforms overall are
more deliverable, requiring less force, than ﬁrst generation DES platforms.CRT-161
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BACKGROUND Coronary stent deployment outcomes can be negatively impacted by
inaccurate lesion measurement and inappropriate stent length selection (SLS). We
compared the manual measurement of these parameters to those provided by the
CorPath 200 Robotic PCI System.
METHODS Sixty consecutive patients who underwent coronary stent placement uti-
lizing the CorPath System were evaluated. The treating physician assessed orthogonal
images and provided visual estimates of lesion length and SLS. The robotic system
was then used for the same measures. SLS was considered to be accurate when
manual and robotic measures were in agreement. Manual SLSs were considered to be
“short” or “long” if they were below or above the robotic-selected stents,
respectively.
RESULTS Only 35% (21/60) of visually estimated lesions resulted in accurate SLS.
Whereas, 33% (20/60) and 32% (19/60) of the manually-determined SLSs were long
and short, respectively. In 5 cases (8.3%), 1 less stent was placed based on the robotic
lesion measurement being shorter than the visual estimate (TABLE 1).
CONCLUSIONS Manual assessment of lesion length and SLS is highly variable with
65% of the cases being inaccurately measured when compared to objective measures
obtained from the robotic system. The 32% of the cases where lesions were visually
estimated to be short represents cases that often require the use of extra stents after
the full lesion is not covered by 1 stent [Longitudinal Geographic Miss (LGM)].
Further, these data showed that the use of the robotic system prevented the use of
extra stents in 8.3% of the cases. Measurement of lesions with robotic PCI may reduce
measurement errors, need for extra stents, and LGM.
Table 1. Cases with Deﬁnite Stent SavingsCaseVisual
Measurement (mm)Visual Stent Length
Selection (mm)CorPath
Measurement (mm)Final Stent Length
Chosen (mm)1 38 23+18 34.9 382 46 24+24 38.0 383 52 24+28 37.7 384 44 24+20 28.0 325 40 18+23 35.1 38CRT-162
Hybrid Approach of Percutaneous Coronary Intervention Followed by Minimally
Invasive Valve Surgery for Patients with Concomitant Coronary Artery and
Valvular Heart Disease and Severely Reduced Left Ventricular Systolic Function
Andres M. Pineda, Juan Pablo Rodriguez-Escudero, Christos G. Mihos, Rama Krishna,
Orlando Santana, Nirat Beohar
Mount Sinai Medical Center, Miami Beach, FL
BACKGROUND The subset of patients with severely reduced left ventricular systolic
function requiring coronary revascularization and valve surgery are at increased risk
for adverse post-operative outcomes. They may beneﬁt from a hybrid approach of
percutaneous coronary intervention (PCI) followed by minimally invasive valve sur-
gery (MIVS), rather than a combined median sternotomy coronary artery bypass graft
and valve surgery.
